Organogenesis Holdings (ORGO) Consolidated Net Income (2016 - 2026)

Organogenesis Holdings' Consolidated Net Income history runs 11 years deep, the most recent figure standing at -$53.2 million for Q1 2026.

• On a quarterly basis, Consolidated Net Income fell 182.1% year-over-year to -$53.2 million in Q1 2026; TTM through Mar 2026 was $8.1 million, a 151.15% increase from a year earlier, with the FY2025 full-year figure at $42.4 million, up 4828.8% from the prior year.
• Consolidated Net Income eased to -$53.2 million in Q1 2026 per ORGO's latest filing, from $49.1 million in the prior quarter.
• Across five years, Consolidated Net Income topped out at $49.1 million in Q4 2025 and bottomed at -$53.2 million in Q1 2026.
• The 5-year median for Consolidated Net Income is $1.4 million (2023), against an average of $743058.8.
• Across the five-year window, Consolidated Net Income jumped 1373.02% in 2023 and plunged 797.29% in 2025, its largest moves.
• Year by year, Consolidated Net Income stood at $7.5 million in 2022, then sank by 80.71% to $1.4 million in 2023, then jumped by 431.37% to $7.7 million in 2024, then surged by 539.97% to $49.1 million in 2025, then slumped by 208.25% to -$53.2 million in 2026.
• Per Business Quant, the three latest ORGO Consolidated Net Income figures stand at -$53.2 million (Q1 2026), $49.1 million (Q4 2025), and $21.6 million (Q3 2025).